| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0140-6736(99)01313-6 |
| P698 | PubMed publication ID | 10334274 |
| P2093 | author name string | J M Besson | |
| P2860 | cites work | Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene | Q24314289 |
| The capsaicin receptor: a heat-activated ion channel in the pain pathway | Q24322558 | ||
| Altered nociception, analgesia and aggression in mice lacking the receptor for substance P | Q24322842 | ||
| A proton-gated cation channel involved in acid-sensing | Q24329227 | ||
| Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing | Q24563789 | ||
| The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 | Q27731226 | ||
| Pain mechanisms: a new theory | Q28251567 | ||
| Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications | Q28287619 | ||
| Primary afferent tachykinins are required to experience moderate to intense pain | Q28506575 | ||
| A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons | Q28570486 | ||
| The cloned capsaicin receptor integrates multiple pain-producing stimuli | Q29547511 | ||
| Pain processing during three levels of noxious stimulation produces differential patterns of central activity. | Q32118697 | ||
| Neuropathic pain: aetiology, symptoms, mechanisms, and management | Q33661273 | ||
| Opiate analgesics inhibit substance P release from rat trigeminal nucleus | Q39156657 | ||
| New molecules in analgesia | Q39372738 | ||
| Peripheral and spinal mechanisms of nociception | Q39755865 | ||
| Spinal opiate analgesia: Characteristics and principles of action | Q40128120 | ||
| Messenger plasticity in primary sensory neurons following axotomy and its functional implications | Q40387628 | ||
| Spinal cord pharmacology of pain | Q40424056 | ||
| New insights into the mode of action of anti-inflammatory drugs | Q40476391 | ||
| Afferent and spinal mechanisms of joint pain | Q40799536 | ||
| Nitric oxide (NO) and nociceptive processing in the spinal cord | Q40887811 | ||
| Peptides and the primary afferent nociceptor | Q40911083 | ||
| Purinergic receptors: their role in nociception and primary afferent neurotransmission | Q41103378 | ||
| Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma | Q41330826 | ||
| Neuroanatomy of the pain system and of the pathways that modulate pain | Q41334057 | ||
| Peripheral pain mechanisms | Q41587254 | ||
| Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 | ||
| Null mutations lacking substance: elucidating pain mechanisms by genetic pharmacology | Q47877229 | ||
| Getting a line on pain: is it mediated by dedicated pathways? | Q48243898 | ||
| Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor | Q73763175 | ||
| P433 | issue | 9164 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurobiology | Q2728012 |
| P304 | page(s) | 1610-1615 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | The neurobiology of pain | |
| P478 | volume | 353 |
| Q90579923 | A Neurobehavioral Approach to Addiction: Implications for the Opioid Epidemic and the Psychology of Addiction |
| Q39296701 | A preliminary investigation into the practicality of use and duration of action of slow-release preparations of morphine and hydromorphone in laboratory rats. |
| Q32090449 | Absence of abdominal pain in older persons with endoscopic ulcers: a prospective study |
| Q33665509 | Acute pain |
| Q38097474 | An improved understanding of neuropathic pain |
| Q40098880 | Analgesic and Antioxidant Activities of Stem Bark Extract and Fractions of Petersianthus macrocarpus |
| Q44193345 | Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. |
| Q34117743 | Anticonvulsants in neuropathic pain: rationale and clinical evidence |
| Q40358265 | Antinociceptive and anti-inflammatory properties of 7-hydroxycoumarin in experimental animal models: potential therapeutic for the control of inflammatory chronic pain |
| Q44426198 | Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin‐catabolizing enzymes, are enhanced by (+)‐HA966, a functional NMDA receptor antagonist: a c‐Fos study in the rat spinal cord |
| Q41822843 | Antinociceptive effects of gabapentin & its mechanism of action in experimental animal studies. |
| Q37399423 | Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review |
| Q36646332 | At the crossroads between tension-type headache and fibromyalgia |
| Q48228055 | Avulsion injury of the rat brachial plexus triggers hyperalgesia and allodynia in the hindpaws: a new model for the study of neuropathic pain |
| Q46954357 | Central modulation of exercise-induced muscle pain in humans. |
| Q60731389 | Chapter 34 Classification of neuropathic pain syndromes based on symptoms and signs |
| Q36772936 | Chronic neuropathic pain: mechanisms, drug targets and measurement |
| Q74566069 | Chronic pain after sternotomy |
| Q61814499 | Development and preliminary evaluation of a short self-report measure of generalized pain hypersensitivity |
| Q73839591 | Diagnosis and management of neuropathic pain in patients with cancer |
| Q53142874 | Diagnostic value of some less frequently considered blink reflex parameters in idiopathic trigeminal neuralgia. |
| Q36107007 | Do minimally invasive procedures have a place in the treatment of chronic low back pain? |
| Q33208901 | Drug seeking behavior |
| Q93053266 | Effect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: in vivo and ex vivo analysis |
| Q36304970 | Effect of photobiomodulation therapy (808 nm) in the control of neuropathic pain in mice. |
| Q44141635 | Effect of quercetin on plasma extravasation in rat CNS and dura mater by ACE and NEP inhibition |
| Q34489823 | Effects of peptides on animal and human behavior: a review of studies published in the first twenty years of the journal Peptides |
| Q41073623 | Emergent stochastic oscillations and signal detection in tree networks of excitable elements |
| Q60688661 | Expression of metabotropic glutamate receptors mRNA in the thalamus and brainstem of monoarthritic rats |
| Q37809229 | Fish Analgesia: Pain, Stress, Fear Aversion, or Nociception? |
| Q37993955 | Fixed-dose combinations for emerging treatment of pain |
| Q38608221 | From pulses to pain relief: an update on the mechanisms of rTMS-induced analgesic effects. |
| Q37479415 | GRIN1 regulates micro-opioid receptor activities by tethering the receptor and G protein in the lipid raft |
| Q35650460 | Glutaminase immunoreactivity and enzyme activity is increased in the rat dorsal root ganglion following peripheral inflammation |
| Q34421461 | Has basic research contributed to chronic pain treatment? |
| Q37189598 | Histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation |
| Q38662487 | How to diagnose fibromyalgia |
| Q35813151 | Hyperalgesia in outpatients with dermal injury: quantitative sensory testing versus a novel simple technique |
| Q34763622 | In vivo activation of a mutant mu-opioid receptor by antagonist: future direction for opiate pain treatment paradigm that lacks undesirable side effects |
| Q34203887 | Individual differences in prefrontal cortex function and the transition from drug use to drug dependence |
| Q33816801 | Local anesthesia in surgical practice |
| Q33995639 | Management of cancer pain. |
| Q36577250 | Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis |
| Q41975280 | Medial plantar nerve ligation as a novel model of neuropathic pain in mice: pharmacological and molecular characterization |
| Q38211273 | Modulating the delicate glial-neuronal interactions in neuropathic pain: promises and potential caveats |
| Q36941918 | Multiple sclerosis symptom management |
| Q38164130 | Natural products evaluated in neuropathic pain models - a systematic review. |
| Q47923351 | Neuroanatomy and Neuropsychology of Pain |
| Q37225466 | Neurobiology of pain in children: an overview |
| Q38926264 | Neurokinin 1 and opioid receptors: relationships and interactions in nervous system |
| Q37417613 | Neurokinins inhibit low threshold inactivating K+ currents in capsaicin responsive DRG neurons |
| Q61805142 | Neurons and Microglia; A Sickly-Sweet Duo in Diabetic Pain Neuropathy |
| Q43826484 | Novel effect of nefopam preventing cGMP increase, oxygen radical formation and neuronal death induced by veratridine. |
| Q41819377 | Opiate Analgesia Treatment Reduced Early Inflammatory Response After Severe Chest Injuries |
| Q34614499 | Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients |
| Q73086498 | Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia |
| Q35015961 | Pain Management Doesn't have to be a Pain: Working and Communicating Effectively with Patients who have Chronic Pain |
| Q38816684 | Pain in pancreatic cancer: review of medical and surgical remedies |
| Q42939092 | Pain management after cardiac surgery |
| Q39196644 | Pain management in the emergency chain: the use and effectiveness of pain management in patients with acute musculoskeletal pain |
| Q36224081 | Pain processing in the human nervous system: a selective review of nociceptive and biobehavioral pathways |
| Q24646738 | Pathological and protective roles of glia in chronic pain |
| Q34293335 | Pharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism |
| Q37907386 | Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature |
| Q33953961 | Pharmacology of oral combination analgesics: rational therapy for pain |
| Q39425658 | Preemptive bupivacaine offers no advantages to postoperative wound infiltration in analgesia for outpatient breast biopsy |
| Q37346193 | Preventive potentials of piperlongumine and a Piper longum extract against stress responses and pain |
| Q34397678 | Recent advances in pain research: implications for chronic headache. |
| Q36022149 | Recent advances in the neurophysiology of chronic pain |
| Q56963543 | Reduced Nerve Injury-Induced Neuropathic Pain in Kinin B1 Receptor Knock-Out Mice |
| Q38878738 | Reduction of anion reversal potential subverts the inhibitory control of firing rate in spinal lamina I neurons: towards a biophysical basis for neuropathic pain |
| Q42665192 | Reward circuitry activation by noxious thermal stimuli |
| Q55253332 | Subliminal (latent) processing of pain and its evolution to conscious awareness. |
| Q43757145 | Synergistic mu-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons |
| Q44425438 | Systemic side effects of topical latanoprost |
| Q48375479 | Tactile sensory and pain networks in the human spinal cord and brain stem mapped by means of functional MR imaging |
| Q38703633 | Targeting Epigenetic Mechanisms for Chronic Pain: A Valid Approach for the Development of Novel Therapeutics |
| Q59809225 | The Contribution of Endogenous Modulatory Systems to TMS- and tDCS-Induced Analgesia: Evidence from PET Studies |
| Q26860726 | The Efficacy and Clinical Safety of Various Analgesic Combinations for Post-Operative Pain after Third Molar Surgery: A Systematic Review and Meta-Analysis |
| Q34120824 | The alleviation of pain by cell transplantation |
| Q44321729 | The amelioration of the suffering associated with spinal cord injury with subperception transcranial electrical stimulation |
| Q35779153 | The amygdala and persistent pain |
| Q35627896 | The association of gastroesophageal reflux disease with asthma and chronic cough in the adult |
| Q30884850 | The basics behind bladder pain: a review of data on lower urinary tract sensations |
| Q37294164 | The c-kit signaling pathway is involved in the development of persistent pain |
| Q34430594 | The clinical picture of neuropathic pain. |
| Q33597256 | The comparative preemptive analgesic efficacy of addition of vitamin B complex to gabapentin versus gabapentin alone in women undergoing cesarean section under spinal anesthesia: A prospective randomized double-blind study |
| Q44257696 | The consequences of chronic pain |
| Q26824011 | The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways |
| Q44178878 | The effects of diphenhydramine and SR142948A on periaqueductal gray neurons and on the interactions between the medial preoptic nucleus and the periaqueductal gray |
| Q34775105 | The nature of work-related neck and upper limb musculoskeletal disorders |
| Q35963976 | The nursing role in recognizing and assessing neuropathic pain |
| Q34126167 | The pharmacological basis of contemporary pain management |
| Q38439654 | The role of sleep in pain and fibromyalgia |
| Q36103777 | The role of sodium channels in chronic pain |
| Q35030056 | The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? |
| Q36253073 | Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder |
| Q43061966 | Treating chronic pain: the need for non-opioid options |
| Q36455922 | Trigeminal Neuralgia and Radiofrequency Lesioning |
| Q38828988 | Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways |
| Q37074313 | Understanding the nature and mechanism of foot pain |
| Q44658262 | Up‐regulation of fatty acid metabolizing‐enzymes mRNA in rat spinal cord during persistent peripheral local inflammation |
| Q37862626 | Use of acupuncture as a treatment method for chronic prostatitis/chronic pelvic pain syndromes |
| Q50868192 | Visceral hypersensitivity in non-erosive reflux disease: neurogenic overwhelming in esophagus? |
Search more.